Article excerpt
Highlighted: the sentence this signal was extracted from
Saccaro's Appointment is Effective August 17, 2026; Wetteny Joseph to Serve as a Special Advisor to the CEO on Financial Matters Until Early 2027 PARSIPPANY, N.J. --(BUSINESS WIRE)--Aug. 6, 2026-- Zoetis Inc. (NYSE: ZTS) today announced the appointment of James (Jay) Saccaro as Executive Vice President, Chief Financial Officer and Chief Operating Officer, effective August 17, 2026. In this newly created role, Mr. Saccaro will lead Zoetis' global finance function, shaping capital allocation, financial strategy, reporting and controls, and investor engagement and oversee Global Manufacturing and Supply to drive operational execution and performance. With Mr. Saccaro's appointment, Wetteny Joseph will transition to an advisory role effective August 17, 2026 . Mr. Joseph has agreed to remain with the company as a Special Advisor to the CEO on financial matters until early 2027 to facilitate a smooth transition. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260805820439/en/ Mr. Saccaro joins Zoetis with extensive executive leadership experience at large-scale life sciences companies. He most recently served as Vice President and CFO at GE HealthCare, where he led key initiatives for the newly established public company, including designing processes and approaches across finance, accounting, new product planning...
Keep reading with a free account
The rest of this article, and every signal for Zoetis, is in your free account.